Ga direct naar de inhoud, het hoofdmenu, het servicemenu of het zoekveld.



  • Simple genetic test predicts safety of commonly used anti-cancer drugs

    As much as one out of twenty cancer patients who receive chemotherapy with a drug from the class of the fluoropyrimidines will get a severe adverse drug reaction. This reaction can even be lethal. Researchers of the Netherlands Cancer Institute (NKI) have developed a simple genetic test that predicts whether these drugs will be safe for a patient.

    Read More
  • On Friday, November 20th Jarich Spliethoff will defend his thesis

    The thesis is entitled 'Spectral tissue sensing for guidance and monitoring in oncological procedures'. His promotors are Prof. dr. Theo Ruers en Dr. Benno Hendriks. The public defense will take place at 16:15 h at the Waaier', University of Twente, Drienerlolaan 5 in Enschede.

    Read More
  • More news

Comprehensive Cancer Centre

'The Netherlands Cancer Institute, a center of excellence for the benefit of cancer patients.'

Support Us